Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mais Alkyam"'
Autor:
Hikmat Abdel-Razeq, Baha' Sharaf, Hira Bani Hani, Ramiz Abu Hijlih, Mais Alkyam, Khansa Al-Azzam, Shatha Elemian, Abdelghani Tbakhi, Areej Al-Atary, Rachel E. Ellsworth, Emily M. Russell, Edward D. Esplin, Malek Horani, Zeidan Zeidan, Abdulla Alzibdeh, Brandie Heald, Sarah M. Nielsen, Robert L. Nussbaum
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEGermline genetic testing (GGT) significantly affects cancer care. While universal testing has been studied in Western societies, less is known about adoption elsewhere.MATERIALS AND METHODSIn this study, 3,319 unselected, pan-cancer Jordanian
Externí odkaz:
https://doaj.org/article/7d5166b37872449cb505823fc6b1095c
Autor:
Hikmat Abdel-Razeq, Rawan Mustafa, Sarah Abdel-Razeq, Hala Abu-Fares, Sama Al Masri, Rana Damsees, Mariam El-Atrash, Shatha Elemian, Mais Alkyam, Khawlah Ammar, Rayan Bater, Marah Kderat, Abdulrahman Alhajahjeh
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Background: Breast cancer susceptibility genes such as BRCA1, BRCA2, PALB2, CHEK2 and many others are increasingly recognized among our patient population. In addition to their impact on treatment decisions of tested patients themselves, identifying
Externí odkaz:
https://doaj.org/article/8969c859312547a493dd135867181475
Autor:
Hikmat Abdel‐Razeq, Khansa Al‐Azzam, Shatha Elemian, Hala Abu‐Fares, Areej Abu Sheikha, Hira Bani Hani, Rayan Bater, Baha’ Sharaf, Brandie Heald, Edward D. Esplin, Sarah M. Nielsen, Mais Alkyam, Lama Abujamous, Areej Al‐Attary
Publikováno v:
Molecular Genetics & Genomic Medicine, Vol 11, Iss 4, Pp n/a-n/a (2023)
Abstract Background Ovarian cancer is one of the most common gynecological malignancies. Due to the absence of effective screening methods, ovarian cancer is usually diagnosed at late stages. Patients with pathogenic and likely‐pathogenic germline
Externí odkaz:
https://doaj.org/article/0dae60de389a4f7dbdd08820096a6984
Autor:
Hikmat Abdel-Razeq, Lama Abujamous, Khansa Al-Azzam, Hala Abu-Fares, Hira Bani Hani, Mais Alkyam, Baha' Sharaf, Shatha Elemian, Faris Tamimi, Fawzi Abuhijla, Sarah Edaily, Osama Salama, Hazem Abdulelah, Rand Daoud, Mohammad Abubaker, Areej Al-Atary
Publikováno v:
Breast Cancer: Targets and Therapy. 15:1-10
Hikmat Abdel-Razeq,1,2 Lama Abujamous,3 Khansa Al-Azzam,1 Hala Abu-Fares,1 Hira Bani Hani,1 Mais Alkyam,1 Bahaâ Sharaf,1 Shatha Elemian,1 Faris Tamimi,1 Fawzi Abuhijla,4 Sarah Edaily,1 Osama Salama,1 Hazem Abdulelah,1 Rand Daoud,1 Mohammad Abuba
Autor:
Hikmat Abdel‐Razeq, Khansa Al‐Azzam, Shatha Elemian, Hala Abu‐Fares, Areej Abu Sheikha, Hira Bani Hani, Rayan Bater, Baha’ Sharaf, Brandie Heald, Edward D. Esplin, Sarah M. Nielsen, Mais Alkyam, Lama Abujamous, Areej Al‐Attary
Publikováno v:
Molecular geneticsgenomic medicineREFERENCES.
Ovarian cancer is one of the most common gynecological malignancies. Due to the absence of effective screening methods, ovarian cancer is usually diagnosed at late stages. Patients with pathogenic and likely-pathogenic germline variants (PGVs) in BRC
Autor:
Khansa Al-Azzam, Hala Abu-Fares, Areej Abu Sheikha, Lama Abujamous, Mais Alkyam, Hira Bani Hani, Rayan Bater, Brandie Heald, Edward D. Esplin, Hikmat Abdel-Razeq
Publikováno v:
Journal of Clinical Oncology. 40:e17593-e17593
e17593 Background: Ovarian cancer is one of the most common gynecological malignancies. Because of the absence of effective screening methods, ovarian cancer is usually diagnosed at late stages contributing to high mortality rates. Patients with BRCA